๐ฆ๐๐: ๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป ๐ง๐ถ๐บ๐ฒ ๐ฎ๐น ๐ฆ๐ฒ๐ป๐ฎ๐๐ผ ๐ฑ๐ฒ๐น๐น๐ฎ ๐ฅ๐ฒ๐ฝ๐๐ฏ๐ฏ๐น๐ถ๐ฐ๐ฎ ๐ฎ๐น
Giovedรฌ 30 aprile dalle ore 15:00 in diretta su @RaiTre l'interrogazione parlamentare a firma del senatore @FraMirabelli.
Weโre pleased to share the publication of a new research study now available in @ANA_journals#ACTN, demonstrating a correlation between longitudinal biomarker data and clinical outcomes in patients with #ALS, including markers of oxidative stress, systemic inflammation, and axonal injury.
These findings further support the mechanistic rationale for COYA 302, Coyaโs investigational therapy designed to modulate immune dysfunction and neuroinflammation. Weโre encouraged by the growing body of evidence reinforcing the role of immune pathways in ALS and remain committed to advancing innovative approaches for patients.
For more details: https://t.co/n6mZousw2u
#NeurodegenerativeDisease #ALSawareness #EndALS American Neurological Association
Coyaโs President & CMO Dr. Fred Grossman and VP of Patient Advocacy @FamilialALS are on the ground at #SuperBowlLX Radio Row, joining @SolomonsWisdom to discuss how Coya is advancing a new treatment approach for #ALS.
Former @NFL players have played a powerful role in raising awareness around ALS. Notable voices such as Steve Gleason, Tim Green, and Dwight Clark have courageously shared their journeys, helping shine a national spotlight on the urgent need for research and innovation.
Weโre honored to be part of the conversation and remain committed to advancing science that may meaningfully impact patients and families affected by ALS.
ICYMI I wanted to share the amazing @TODAYshow interview of me and @sabrevaya and all of the things that we have been up to. Thank you @jacobsoboroff and @mollymhunter for the chance to share our story with the world!
#EUpALS is proud to be partner in EU Horizon project HEREDITARY that runs 2024-2027. #HEREDITARY uses Artificial Intelligence for heterogeneous semantic data integration for the gut-brain interplay. #ALS/#MND is a usecase. Today, we met all partners at the kick-off meeting.
Caro @Fedez, visto il tuo potere mediatico, potresti fare un appello al governo affinchรฉ finanzi la ricerca contro la SLA?
La comunitร dei malati di #SLA ha un'enorme necessitร di aiuto.
Grazie
@SKyriakidesEU@EU_Commission@EU_Health Dear Ms Kyriakides, thank you for this amazing effort in the fight against cancer. Remarkable.
Please do the same for Amyotrophic Lateral Sclerosis: a life-threatening illness, 100% fatal, a real unmet need.
#EndALS#PostFataResurgo
#ildirittochemimanca รจ quello di avere una cura per la SLA.
Investire sulla ricerca scientifica non puรฒ essere opzionale, deve essere un chiaro obiettivo per risolvere questo tremendo problema - la SLA.
Dona il tuo 5x1000 a ๐ฃ๐ผ๐๐ ๐๐ฎ๐๐ฎ ๐ฅ๐ฒ๐๐๐ฟ๐ด๐ผ indicando il ๐๐ผ๐ฑ๐ถ๐ฐ๐ฒ ๐๐ถ๐๐ฐ๐ฎ๐น๐ฒ ๐ต๐ฏ๐ฎ๐ฏ๐ณ๐ฒ๐ฑ๐ฌ๐ด๐ณ๐ต nella sezione ๐๐๐๐๐๐๐๐ ๐ฟ๐๐๐๐ ๐๐๐๐ ๐ฟ๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐๐พ๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐ nella tua denuncia dei redditi.
$CLNN to present highly encouraging clinical data at the 2023 Annual Meeting of the American Academy of Neurology (@AANmember) #AAN2023#AANAM
Learn more: https://t.co/XmLFdRjsDg
COYA 302 (biologics combination therapy) clinical and biomarkers data in patients with Amyotrophic Lateral Sclerosis (#ALS) will be presented in Q1 2023. More info: https://t.co/DgIiEAeaEH $COYA #EndALS